“…L-carnitine was orally administered and the intervention dose ranged between 500 to 4000 mg/day. For the control groups, ten trials used placebo controls (35,36,39,44,(79)(80)(81)(82)(83)(84), six trials did not prescribe any treatment (37,(40)(41)(42)(43)77), and three trials used drugs such as interferon-α, ribavirin, and entecavir, in which participants in the intervention group also received these drugs in addition to L-carnitine (38,47,78). The majority of trials included either gender, with the age ranging from 18 to 85 years.…”